Addition of Inotuzumab Ozogamicin to the Conditioning Regimen of Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed CD22 (+) Lymphoid Malignancies: Long-Term Survival Results F. Khouri,Kamal Alzahrani,Alison Gulbis,Koji Sasaki,Nitin Jain, Nicholas J. Short,Tapan M. Kadia,May Daher,Hind Rafei,Jin S. Im,David Marin,Amanda L. Olson,Uday R. Popat,Muzaffar H. Qazilbash,Jeremy Ramdial,Gabriela Rondon,Samer A. Srour,Partow Kebriaei,Elizabeth J. Shpall,Hagop M. Kantarjian,Richard E. Champlin,Elias JabbourBLOOD（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
